Inventor · disambiguated record
Masatoshi Hagiwara
Also filed as: HAGIWARA MASATOSHI
22 granted patents·13 pending applications·128 citations·filing 1989–2024
93Inventor score
Top patents by PatentIndex Score
35 records- 0193US7786151B2Therapeutic composition of treating abnormal splicing caused by the excessive kinase inductionKINOPHARMA INC·Filed 2005·Granted Aug 31, 2010·20 cites·6 claims
- 0282US9273364B2Transgenic reporter system that reveals expression profiles and regulation mechanisms of alternative splicing in mammalian organismsHAGIWARA MASATOSHI·Filed 2011·Granted Mar 1, 2016·3 cites·10 claims
- 0382US5081246ACompound having vessel smooth muscle relaxation activityHIDAKA HIROYOSHI·Filed 1989·Granted Jan 14, 1992·23 cites·2 claims
- 0480US7739013B2Vehicular electronic control apparatus and method for controlling vehicleFUJITSU TEN LTD·Filed 2005·Granted Jun 15, 2010·18 cites·9 claims
- 0579US7280908B2Vehicle controller and vehicle control methodFUJITSU TEN LTD·Filed 2005·Granted Oct 9, 2007·14 cites·35 claims
- 0677US11318126B2Composition for activating neurogenesisUNIV KYOTO·Filed 2017·Granted May 3, 2022·2 cites·3 claims
- 0777US7569536B2Method for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activityHAGIWARA MASATOSHI·Filed 2004·Granted Aug 4, 2009·10 cites·7 claims
- 0874US10281446B2Engine control deviceFUJITSU TEN LTD·Filed 2017·Granted May 7, 2019·1 cites·5 claims
- 0973US9745323B2Compound and pharmaceutical composition for neuropsychological disorder or malignant tumorUNIV KYOTO·Filed 2013·Granted Aug 29, 2017·3 cites·9 claims
- 1073US7928283B2Transgenic reporter system that reveals expression profiles and regulation mechanisms of alternative splicing in nematodesKINOPHARMA INC·Filed 2007·Granted Apr 19, 2011·2 cites·8 claims
- 1172US5216150ADerivatives of isoquinoline (and naphthalene) sulfonamidesHIDAKA HIROYOSHI·Filed 1991·Granted Jun 1, 1993·16 cites·1 claims
- 1271US5245034ACompound having vessel smooth muscle relaxation activityHIDAKA KIROYOSHI·Filed 1992·Granted Sep 14, 1993·16 cites·2 claims
- 1366US11628827B2Vehicle control device and control methodDENSO TEN LTD·Filed 2021·Granted Apr 18, 2023·0 cites·25 claims
- 1464US8338362B2Methods for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activityHAGIWARA MASATOSHI·Filed 2009·Granted Dec 25, 2012·0 cites·10 claims
- 1561US2024222989A1Charging control device and charging control methodDENSO TEN LTD·Filed 2024·Application pending·0 cites
- 1660US12023338B2Pharmaceutical composition and treatment method for genetic disease associated with splicing abnormalitiesUNIV KYOTO·Filed 2021·Granted Jul 2, 2024·0 cites·6 claims
- 1757US8816089B2Methods for controlling SR protein phosphorylation, and antiviral agents whose active ingredients comprise agents that control SR protein activityHAGIWARA MASATOSHI·Filed 2012·Granted Aug 26, 2014·0 cites·6 claims
- 1856US2021204539A1Method for Suppressing Freezing Damage and Composition for Preventing Freezing DamageUNIV KYOTO·Filed 2019·Application pending·0 cites
- 1956US2024358684A1Method for enhancing innate immune responseUNIV KYOTO·Filed 2022·Application pending·0 cites
- 2053US2019365762A1Medicinal composition inhibiting neovascularization proliferation factorUNIV KYOTO·Filed 2019·Application pending·0 cites
- 2151US2020113907A1Pharmaceutical composition and treatment method for genetic disease associated with splicing abnormalitiesUNIV KYOTO·Filed 2018·Application pending·0 cites
- 2250US2024423988A1Improvement of Tumor Immunogenicity by Means of Splicing-Controlling CompoundUNIV KYOTO·Filed 2022·Application pending·0 cites
- 2347US9879014B2Method for screening substance capable of inhibiting abnormal splicing causative of onset or progress of diseaseUNIV KYOTO·Filed 2014·Granted Jan 30, 2018·0 cites·5 claims
- 2447US2016303089A1Compound pertaining to neuropoiesis and drug compositionUNIV KYOTO·Filed 2014·Application pending·0 cites
- 2546US2023372309A1Alpha-2 adrenergic receptor antagonistUNIV KYOTO·Filed 2021·Application pending·0 cites
- 2645US10017524B2Compound and pharmaceutical composition for neuropsychological disorder or malignant tumorUNIV KYOTO·Filed 2017·Granted Jul 10, 2018·0 cites·9 claims
- 2744US9745275B2Pain-related compound and medical compositionUNIV KYOTO·Filed 2014·Granted Aug 29, 2017·0 cites·11 claims
- 2844US2022226341A1Pharmaceutical Composition for Alzheimer's DiseaseUNIV KYOTO·Filed 2020·Application pending·0 cites
- 2943US8765941B2Aniline derivative having anti-RNA viral activityONOGI HIROSHI·Filed 2009·Granted Jul 1, 2014·0 cites·2 claims
- 3042US2020188382A1Pharmaceutical composition for inducing programmed cell death in cancer cellsUNIV KYOTO·Filed 2017·Application pending·0 cites
- 3141US2017128449A1Medicinal composition inhibiting neovascularization proliferation factorUNIV KYOTO·Filed 2015·Application pending·0 cites
- 3241US2015133467A1Screening method, protein instability and/or stability inducers, and protein activity assessmentUNIV KYOTO·Filed 2013·Application pending·0 cites
- 3340US12138253B2Tumor suppressionUNIV KYOTO·Filed 2020·Granted Nov 12, 2024·0 cites·11 claims
- 3438US2018290979A1Composition having compound accelerating phosphorylation of ampk as effective componentUNIV KYOTO·Filed 2016·Application pending·0 cites
- 3535US9241929B2Prophylactic or ameliorating agent for genetic diseasesHAGIWARA MASATOSHI·Filed 2011·Granted Jan 26, 2016·0 cites·10 claims
Join the waitlist — get patent alerts
Get an alert when Masatoshi Hagiwara files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →